Regarding the implication of miR-221/-222 in the cancers’ pathological process, it targets the following genes p27Kip1, CDKN1C/p57, E-cadherin, PTPμ, PUMA, ARID1A, AHR1 [324]. The gene discussed is CDKN1C; the disease is cancer.